This market data illustrates the significant potential for neurotech treatments across a range of common health conditions.

Challenges and Future Directions

Despite the promising outlook, the path to commercializing non-invasive neurotech treatments is not without its challenges. Some of the key hurdles identified in the article include:

1. Translating theoretical work into clinically validated outcomes: This involves convincing investors to take a bet on novel treatments and persuading doctors to involve their patients in clinical trials.